The Royal Society
Rhiannon Lowe is an experienced Principal Scientist and Toxicologist currently working at BenevolentAI, leading safety studies for the company's drug discovery and development portfolio. Prior to this role, Rhiannon has worked at GSK as an Investigator in Immunotoxicology and Preclinical Gene Therapy, and as a Senior Scientist on various projects. Lowe has also been involved in CRACK IT project Challenge 21: InMutaGene, STEM Ambassador roles, and has a strong educational background with a PhD in Virology/Immunology from Imperial College London. Rhiannon's expertise spans across various disease indications and Rhiannon has a proven track record of successful collaborations with multidisciplinary teams and outsourcing partners.
This person is not in any teams
The Royal Society
The Royal Society is the world's oldest scientific academy in continuous existence, and has been at the forefront of enquiry and discovery since its foundation in 1660. The backbone of the Society is its Fellowship of the most eminent scientists of the day, elected by peer review for life and entitled to use FRS after their name. There are currently more than 60 Nobel Laureates amongst the Society's approximately 1400 Fellows and Foreign Members. Throughout its history, the Society has promoted excellence in science through its Fellowship and Foreign Membership, which has included Isaac Newton, Charles Darwin, Ernest Rutherford, Albert Einstein, Dorothy Hodgkin, Francis Crick, James Watson and Stephen Hawking. The Society is independent of government, as it has been throughout its existence, by virtue of its Royal Charters. In 1663, The Royal Society of London for the Improvement of Natural Knowledge was granted its Arms and adopted the motto "Nullius in verba", an expression of its enduring commitment to empirical evidence as the basis of knowledge about the natural world. The Society's activities include influencing science and education policy, funding leading researchers, publishing journals that span all the sciences and the history of science, and the provision of science communication activities for a variety of public audiences.